Nexstim Receives NBS 6 System Order from Clinic in Florida, US
Press release, Helsinki, 22 April 2024 at 11 AM (EEST) Nexstim Receives NBS 6 System Order from Clinic in Florida,...
Month: April 2024
Kynos Therapeutics announces positive top-line results from the first-in-human Phase I study of its KMO inhibitor, KNS366, demonstrating safety, tolerability and target engagement
EDINBURGH, United Kingdom, April 22, 2024 (GLOBE NEWSWIRE) -- Kynos Therapeutics Ltd, a clinical-stage biotechnology company developing first-in-class small molecule...
Transactions in Connection with Share Buy-back Program Genmab
Company Announcement COPENHAGEN, Denmark; April 22, 2024 – Genmab A/S (Nasdaq: GMAB). On March 15, 2024, Genmab announced the initiation...
Orion Corporation: Managers’ transactions – Veli-Matti Mattila
ORION CORPORATION MANAGERS’ TRANSACTIONS 22 APRIL 2024 at 9.45 EEST Orion Corporation: Managers’ transactions – Veli-Matti Mattila Orion Corporation has...
SNIPR Biome receives funding from CARB-X to support advancement of CRISPR-medicine SNIPR001 into clinical trials in haematological cancer patients
SNIPR Biome receives funding from CARB-X to support advancement of CRISPR-medicine SNIPR001 into clinical trials in haematological cancer patients Phase...
Nicox Provides First Quarter 2024 Update and Full Year 2023 Financial Results
Press Release Nicox Provides First Quarter 2024 Update and Full Year 2023 Financial Results Nicox Group revenue of €4.4 million...
Celly Nutrition Forges Strategic Partnership with BevSource to Accelerate unbuzzd(TM) Distribution
Toronto, Ontario--(Newsfile Corp. - April 22, 2024) - In a strategic move in preparation of the launch in the United...
Strawberry Fields REIT Completes Dual-Listing and Begins Trading on the Tel Aviv Stock Exchange
South Bend, Indiana--(Newsfile Corp. - April 22, 2024) - Strawberry Fields REIT, Inc. (NYSE American: STRW) ("Strawberry Fields" or the...
Angle PLC Announces US and EU Patents for Innovative CellKeep(TM) Slide
Proprietary cell recovery device and method eliminates over 70% of CTC cell loss from standard microscopy techniques increasing assay sensitivity...
Clinical Endpoint Adjudication: Ethical Enhances eAdjudication(R) With an Innovative AI-Powered Conversational Documents Search
By leveraging advanced natural language processing and machine learning capabilities, Ethical's new AI-powered conversational documents search tool reduces the time...
Ibogaine By David Dardashti Announces New Algorithm For Alcohol Addiction
Revolutionary Method to Combat Alcoholism and Restore Quality of Life Alcohol algorithm New procedures to help those who struggle. MIAMI,...
Ibogaine by David Dardashti Introduces New Algorithm for Methadone Addiction
Algorithm Varies Slightly from Suboxone and Focuses on Continuously Dosed Ibogaine Treatment Methadone algorithm Ibogaine by David Dardashti is improving...
Ibogaine By David Dardashti Introduces New Algorithm for Depression Treatment
A Revolutionary Advancement in Depression Treatments Ibogaine by David Dardashti A new algorithm to help combat depression MIAMI, April 21,...
Discover the Holistic Bliss of Good Organics CBD
As Stress Awareness Month is here this April and Mental Health Awareness Month follows in May, it's the perfect time...
Remedium Healthcare Products Launches NuVeria Labs’ Groundbreaking Sacral Silicone Dressing, Now Available for Purchase on Amazon Prime
Remedium Healthcare Products announces the launch of NuVeria Labs' Sacral Silicone Dressing on Amazon, setting a new standard in accessible,...
Vaxxinity Issues Shareholder Letter
CAPE CANAVERAL, Fla., April 19, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (“Vaxxinity”, “we”, “us” or the “Company”) (Nasdaq: VAXX), a U.S....
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
FLORHAM PARK, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU) (the “Company”), a regenerative medicine company developing placental-derived allogeneic...
FendX Announces Corporate Update
Oakville, Ontario--(Newsfile Corp. - April 19, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or...
NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing
ZÜRICH, SWITZERLAND / ACCESSWIRE / April 19, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...
Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K
CHICAGO, IL / ACCESSWIRE / April 19, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...